journal cover

Chloroquine-resistant malaria

The Journal of Infectious Diseases

Aug 23, 2001

Thomas E Wellems, Christopher V Plowe

Download from

Publisher
PubMed

Abstract

The development of chloroquine as an antimalarial drug and the subsequent evolution of drug-resistant Plasmodium strains had major impacts on global public health in the 20th century. In P. falciparum, the cause of the most lethal human malaria, chloroquine resistance is linked to multi...read more

Mentioned in this Paper

Plasmodium
Phyllostachys vivax
Plasmodium vivax
Malaria, Falciparum
Chloroquine
Malaria
Staphylococcal Protein A
Malaria Vaccines
Membrane Transport Proteins
Plasmodium Measurement
5
6
283
1
Paper Details
References
  • References
  • Citations281
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations281
12345...

Feeds With Similar Papers

National Institute of Allergy & Infectious Diseases (NIAID)

National Institute of Allergy and Infectious Diseases (NIAID) goal is to perform leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases. Follow this feed to stay updated on research from this group.

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Malaria (ASM)

Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. Discover the latest research on malaria here,

National Institute of Allergy & Infectious Diseases (ASM)

National Institute of Allergy and Infectious Diseases (NIAID) goal is to perform leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases. Follow this feed to stay updated on research from this group.

Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Malaria Vaccines (ASM)

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Malaria

Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. Discover the latest research on malaria here,

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

The New England Journal of Medicine

A molecular marker for chloroquine-resistant falciparum malaria

The New England Journal of MedicineFebruary 15, 2001
D C Warhurst
The Journal of Infectious Diseases

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

The Journal of Infectious DiseasesJune 7, 2003
James G KublinChristopher V Plowe
© 2020 Meta ULC. All rights reserved

Chloroquine-resistant malaria

The Journal of Infectious Diseases

Aug 23, 2001

Thomas E Wellems, Christopher V Plowe

PMID: 11517439

DOI: 10.1086/322858

Abstract

The development of chloroquine as an antimalarial drug and the subsequent evolution of drug-resistant Plasmodium strains had major impacts on global public health in the 20th century. In P. falciparum, the cause of the most lethal human malaria, chloroquine resistance is linked to multi...read more

Mentioned in this Paper

Plasmodium
Phyllostachys vivax
Plasmodium vivax
Malaria, Falciparum
Chloroquine
Malaria
Staphylococcal Protein A
Malaria Vaccines
Membrane Transport Proteins
Plasmodium Measurement
5
6
283
1

Feeds With Similar Papers

National Institute of Allergy & Infectious Diseases (NIAID)

National Institute of Allergy and Infectious Diseases (NIAID) goal is to perform leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases. Follow this feed to stay updated on research from this group.

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

Related Papers

The New England Journal of Medicine

A molecular marker for chloroquine-resistant falciparum malaria

The New England Journal of MedicineFebruary 15, 2001
D C Warhurst
The Journal of Infectious Diseases

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

The Journal of Infectious DiseasesJune 7, 2003
James G KublinChristopher V Plowe
Paper Details
References
  • References
  • Citations281
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations281
12345...

Download from

Publisher
PubMed
/papers/chloroquine-resistant-malaria/11517439